FDA Approved: DEFERASIROX — Supplemental Application (Xiromed, LLC)

View source ↗

Summary

The FDA approved a supplemental application for deferasirox filed by Xiromed, LLC under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Iron Overload
• Myelodysplastic Syndrome
• Sickle Cell Disease
• Thalassemia Major

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

SUPPL AP for DEFERASIROX (DEFERASIROX)